Resumo
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- fever/chills
- night sweats, malaise, fatigue, anorexia, weight loss, myalgias
- weakness
- arthralgias
- headache
- shortness of breath
- meningeal signs
- cardiac murmur
- Janeway lesions
- Osler nodes
- Roth spots
Другие диагностические факторы
- splinter hemorrhages
- cutaneous infarcts
- chest pain
- back pain
- palatal petechiae
Факторы риска
- prior history of infectious endocarditis
- presence of artificial prosthetic heart valves
- certain types of congenital heart disease
- postheart transplant (patients who develop a cardiac valvulopathy)
- immunocompromised state
- presence of cardiac implanted electronic device or intravascular catheters (e.g., for hemodialysis)
- acquired degenerative valve disease
- mitral valve prolapse or bicuspid valve prolapse
- hypertrophic cardiomyopathy
- intravenous drug use
- chronic Q fever
Диагностические исследования
Исследования, которые показаны в первую очередь
- blood cultures
- echocardiogram
- CBC
- CRP
- serum chemistry panel with glucose
- LFTs
- urinalysis
- ECG
Исследования, проведение которых нужно рассмотреть
- rheumatoid factor
- erythrocyte sedimentation rate
- complement levels
- cardiac CT
- MRI
- nuclear imaging and PET
- specific tests for blood culture-negative endocarditis
Неотложные исследования
- mean platelet volume (MPV)
- anti‐beta-2‐glycoprotein I antibodies
- D-dimer and troponin I
Алгоритм лечения
suspected infective endocarditis
native valve: confirmed endocarditis
prosthetic valve: confirmed endocarditis
at high risk of infective endocarditis
Составители
Эксперты-консультанты
Carl Zehner, MD
Assistant Professor of Medicine
University of Texas MD Anderson Cancer Center
Department of Cardiology
Houston
TX
Раскрытие информации
CZ declares that he has no competing interests.
Выражение благодарностей
Dr Carl Zehner would like to gratefully acknowledge Dr Ammara Mushtuq, Dr Tracey Keteepe-Arachi, Dr Aneil Malhotra, Dr Michael Papadakis, Professor Sanjay Sharma, Dr Jason C. Schultz, Dr Nisha K. Lassi, and Dr Nandan S. Anavekar, previous contributors to this topic.
Раскрытие информации
TKA, MP, SS, JCS, NKL, and NSA declare that they have no competing interests. AMu declares that she is Principal Investigator on a grant from Merck on ceftolozane-tazobactam, writer for the Lancet family of journals, question writer for Blueprint Test preparations, and a peer-reviewer for Clinical Overviews, Elsevier (topics influenza and HIV). AMa is an author of a number of references cited in this topic.
Рецензенты
Vandana Desai, MD
Professor of Pediatrics
SMIMER Hospital
Gujarat
India
Раскрытие информации
VD declares that she has no competing interests.
Lucieni Oliveira Conterno, MD, PhD
Director
Clinical Epidemiology Unit
Marilia Medical School
Sao Paulo
Brazil
Раскрытие информации
LOC declares that she has no competing interests.
Andrew Wang, MD
Associate Professor of Medicine
Director, Cardiovascular Disease Fellowship Program
Duke University Medical Center
Durham
NC
Раскрытие информации
AW declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86.Полный текст Аннотация
Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042.Полный текст Аннотация
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e72-227.Полный текст Аннотация
Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021 May 18;143(20):e963-78.Полный текст Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Отличия
- Rheumatic fever
- Atrial myxoma
- Libman-Sacks endocarditis
Больше ОтличияРекомендации
- Blood culture-negative endocarditis
- 2023 ESC guidelines for the management of endocarditis
Больше РекомендацииVideos
Venepuncture and phlebotomy: animated demonstration
How to perform an ECG: animated demonstration
Больше ВидеоЛифлеты для пациента
Endocarditis
Больше Лифлеты для пациентаВойдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice
Использование этого контента попадает под действие нашего заявления об отказе от ответственности
